Neuralstem Insider Sells $24,540 in Stock (CUR)
Neuralstem (NYSE:CUR) Insider Karl Johe unloaded 6,000 shares of the company’s stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $4.09, for a total value of $24,540.00. Following the completion of the transaction, the insider now directly owns 495,747 shares in the company, valued at approximately $2,027,605. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Neuralstem (NYSE:CUR) traded down 3.23% on Wednesday, hitting $3.90. The stock had a trading volume of 648,826 shares. Neuralstem has a 52-week low of $1.60 and a 52-week high of $4.81. The stock’s 50-day moving average is $3.39 and its 200-day moving average is $3.77. The company’s market cap is $338.7 million.
Neuralstem (NYSE:CUR) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.05) by $0.03. On average, analysts predict that Neuralstem will post $-0.22 earnings per share for the current fiscal year.
CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.
Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.